Across Europe, the pharmaceutical industry announced that from 2016 it would introduce the disclosure of financial relationships beginning with individual payments made to healthcare professionals and healthcare organisations in 2015.

Gedeon Richter is dedicated to ensuring all our work and activities are delivered to the highest ethical standards and is fully committed to the appropriate use of medicines and the protection of patient safety.

Gedeon Richter UK, along with other pharmaceutical companies, discloses details of payments and support to healthcare professionals and healthcare organisations on a publicly searchable database, Disclosure UK, which can be accessed by visiting https://search.disclosureuk.org.uk/. You can find our disclosure for transfer of value to patient organisations here.